ArticleRMD open2021

Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry.

Ulrich A Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.